Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Urinary Tract Infection (UTI) Treatment Market Snapshot
2.2 Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class
2.3 Global Urinary Tract Infection (UTI) Treatment Market Share, by Geography, 2016 (Value %)
Chapter 3 Urinary Tract Infection (UTI) Treatment Market Analysis
3.1 Global Urinary Tract Infection (UTI) Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Urinary Tract Infection (UTI) Treatment Market
3.5 Top 3 Countries
Chapter 4 Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class
4.1 Overview
4.2 Attractive Investment Proposition: Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class
4.3 Penicillin
4.4 Quinolones
4.5 Cephalosporin
4.6 Sulphonamides
4.7 Tetracycline
4.8 Other
Chapter 5 Global Urinary Tract Infection (UTI) Treatment Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.2.1 North America Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.2.2 North America Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)
5.3 Europe (U.K., Germany & Rest of Europe)
5.3.1 Europe Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.3.2 Europe Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.4.1 Asia Pacific Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.4.1 Asia Pacific Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.5.1 Latin America Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.5.2 Latin America Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)
5.6 Middle East and Africa (GCC and Rest of MEA)
5.6.1 Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.6.2 Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)
Chapter 6 Company Profiles
6.1 AstraZeneca plc.
6.2 Bayer AG
6.3 Cubist Pharmaceuticals
6.4 F. Hoffmann–La Roche Ltd.
6.5 GlaxoSmithKline Pharmaceuticals Ltd.
6.6 Johnson & Johnson
6.7 MerLion Pharmaceuticals
6.8 Osel Inc.
6.9 Pfizer Inc.
6.10 Rempex Pharmaceuticals
List of Figures
FIG. 1 Urinary Tract Infection (UTI) Treatment Market: Research Methodology
FIG. 2 Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2016 (US$ Bn)
FIG. 3 Global Urinary Tract Infection (UTI) Treatment Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global Urinary Tract Infection (UTI) Treatment Market, by Geography, 2016
FIG. 5 Attractive Investment Proposition: Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2016
FIG. 6 Global Penicillin Market, 2015 – 2025 (US$ Bn)
FIG. 7 Global Quinolones Market, 2015 – 2025 (US$ Bn)
FIG. 8 Global Cephalosporin Market, 2015 – 2025 (US$ Bn)
FIG. 9 Global Sulphonamides Market, 2015 – 2025 (US$ Bn)
FIG. 10 Global Tetracycline Market, 2015 – 2025 (US$ Bn)
FIG. 11 Global Other Drugs in UTI treatment Market, 2015 – 2025 (US$ Bn)
List of Tables
TABLE 1 Market Positioning of Key Players in Global Urinary Tract Infection (UTI) Treatment Market
TABLE 2 Top 3 Countries in Global Urinary Tract Infection (UTI) Treatment Market
TABLE 3 Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015 – 2025 (US$ Bn)
TABLE 4 Global Urinary Tract Infection (UTI) Treatment Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 5 North America Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 6 North America Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 7 Europe Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 8 Europe Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 9 Asia Pacific Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 10 Asia Pacific Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 11 Latin America Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 12 Latin America Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 13 Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 14 Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 15 AstraZeneca plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 16 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 17 Cubist Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 18 F. Hoffmann–La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 19 GlaxoSmithKline Pharmaceuticals Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 20 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 21 MerLion Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 22 Osel Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 23 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 24 Rempex Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)